<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<Result buildID="2465" copyright="MIMS Pte Ltd" expiryDate="31/12/2020">
  <Interaction>
    <Product reference="{9FE0E40F-ED39-4EA5-B274-D4FC99CD2753}" name="SPILACTONE FILM-COATED TAB 50mg">
      <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
        <Product reference="{96048B6A-575C-4D10-AE5B-D45DD410BAA5}" name="DICLOACT PLUS TAB">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Potassium sparing diuretics" reference="{B0F33E4A-DD4E-4888-9CAE-225FFCBDB017}" description="These drugs inhibit sodium-potassium exchange in the distal tubule.">
                <PrescribingMolecule name="spironolactone" reference="{74DCDDAF-9349-430F-A2F2-B7F2BC5CD8AA}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <Molecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </InteractionClass>
              <Severity name="Moderate" ranking="4">Moderate</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>
                </Abbreviated>
                <Professional>has its effect reduced by</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Use combination with caution.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor renal function.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor serum potassium.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor blood pressure.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{CCCDB71F-E825-414C-BA3A-E0A665C10AAB}" name="DICLOFEN TAB 50mg">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Potassium sparing diuretics" reference="{B0F33E4A-DD4E-4888-9CAE-225FFCBDB017}" description="These drugs inhibit sodium-potassium exchange in the distal tubule.">
                <PrescribingMolecule name="spironolactone" reference="{74DCDDAF-9349-430F-A2F2-B7F2BC5CD8AA}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <Molecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </InteractionClass>
              <Severity name="Moderate" ranking="4">Moderate</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>
                </Abbreviated>
                <Professional>has its effect reduced by</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Use combination with caution.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor renal function.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor serum potassium.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor blood pressure.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{EDD3FF15-CC25-46C6-80F7-2F8EF72FC502}" name="VIROSTAV TAB 30mg">
        </Product>
        <Product reference="{63B9060F-BFFF-46F0-92FD-ECB299CF917F}" name="ALPYRIN TAB 150mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
      </Route>
    </Product>
    <Product reference="{96048B6A-575C-4D10-AE5B-D45DD410BAA5}" name="DICLOACT PLUS TAB">
      <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
        <Product reference="{9FE0E40F-ED39-4EA5-B274-D4FC99CD2753}" name="SPILACTONE FILM-COATED TAB 50mg" Mirror="True">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <PrescribingMolecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Potassium sparing diuretics" reference="{B0F33E4A-DD4E-4888-9CAE-225FFCBDB017}" description="These drugs inhibit sodium-potassium exchange in the distal tubule.">
                <Molecule name="spironolactone" reference="{74DCDDAF-9349-430F-A2F2-B7F2BC5CD8AA}" />
              </InteractionClass>
              <Severity name="Moderate" ranking="4">Moderate</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>reduces effect of</Abbreviated>
                <Professional>reduces effect of</Professional>
                <Full>decreases effect of</Full>
                <Consumer>decreases effect of</Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Use combination with caution.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor renal function.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor serum potassium.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor blood pressure.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{CCCDB71F-E825-414C-BA3A-E0A665C10AAB}" name="DICLOFEN TAB 50mg">
        </Product>
        <Product reference="{EDD3FF15-CC25-46C6-80F7-2F8EF72FC502}" name="VIROSTAV TAB 30mg">
        </Product>
        <Product reference="{63B9060F-BFFF-46F0-92FD-ECB299CF917F}" name="ALPYRIN TAB 150mg">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <PrescribingMolecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Salicylates (systemic)" reference="{3CCDBD67-FD02-4AF8-B3EB-E54066A7BAD5}" description="Analgesic, antipyretic and anti-inflammatory agents.">
                <Molecule name="aspirin" reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" />
              </InteractionClass>
              <Severity name="Severe" ranking="5">Severe</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>
                </Abbreviated>
                <Professional>causes additive toxicity with</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>The concurrent use of salicylates (e.g. aspirin) and NSAIDs increases the risk of gastrointestinal bleeding. In addition, there is some evidence that NSAIDs may antagonise the antiplatelet effects and reduce the cardioprotective effects of low-dose aspirin. If the use of low-dose aspirin with NSAIDs cannot be avoided, the use of a proton pump inhibitor should be considered. Furthermore, concomitant use of aspirin may result in reduced levels and effects of several NSAIDs; this pharmacokinetic interaction has little clinical relevance as concurrent use of analgesic dose aspirin (or other salicylates) with NSAIDs is usually not recommended.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Avoid combination.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
      </Route>
      <Allergy>
        <Molecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin">
          <CrossSensitive>
            <PrescribingSubstanceClass reference="{5C60F191-B92F-4186-ADF5-859CB3B66E11}" name="Nonsteroidal anti-inflammatory drugs">
              <PrescribingMolecule reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" name="diclofenac sodium" />
            </PrescribingSubstanceClass>
            <AllergySubstanceClass reference="{8B9ECB52-CDC9-4460-AB40-6E3C7DF38B1E}" name="Salicylates">
              <AllergyMolecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin" />
            </AllergySubstanceClass>
          </CrossSensitive>
        </Molecule>
      </Allergy>
      <Allergy>
        <Molecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol">
          <SubstanceClass reference="{50227FDE-1699-4083-92FA-AA75F30A285D}" name="Paracetamol and related agents">
            <PrescribingMolecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol" />
          </SubstanceClass>
        </Molecule>
      </Allergy>
      <Allergy>
        <Molecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol">
          <CrossSensitive>
            <PrescribingSubstanceClass reference="{5C60F191-B92F-4186-ADF5-859CB3B66E11}" name="Nonsteroidal anti-inflammatory drugs">
              <PrescribingMolecule reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" name="diclofenac sodium" />
            </PrescribingSubstanceClass>
            <AllergySubstanceClass reference="{50227FDE-1699-4083-92FA-AA75F30A285D}" name="Paracetamol and related agents">
              <AllergyMolecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol" />
            </AllergySubstanceClass>
          </CrossSensitive>
        </Molecule>
      </Allergy>
    </Product>
    <Product reference="{CCCDB71F-E825-414C-BA3A-E0A665C10AAB}" name="DICLOFEN TAB 50mg">
      <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
        <Product reference="{9FE0E40F-ED39-4EA5-B274-D4FC99CD2753}" name="SPILACTONE FILM-COATED TAB 50mg" Mirror="True">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <PrescribingMolecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Potassium sparing diuretics" reference="{B0F33E4A-DD4E-4888-9CAE-225FFCBDB017}" description="These drugs inhibit sodium-potassium exchange in the distal tubule.">
                <Molecule name="spironolactone" reference="{74DCDDAF-9349-430F-A2F2-B7F2BC5CD8AA}" />
              </InteractionClass>
              <Severity name="Moderate" ranking="4">Moderate</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>reduces effect of</Abbreviated>
                <Professional>reduces effect of</Professional>
                <Full>decreases effect of</Full>
                <Consumer>decreases effect of</Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Use combination with caution.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor renal function.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor serum potassium.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Monitor blood pressure.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{96048B6A-575C-4D10-AE5B-D45DD410BAA5}" name="DICLOACT PLUS TAB">
        </Product>
        <Product reference="{EDD3FF15-CC25-46C6-80F7-2F8EF72FC502}" name="VIROSTAV TAB 30mg">
        </Product>
        <Product reference="{63B9060F-BFFF-46F0-92FD-ECB299CF917F}" name="ALPYRIN TAB 150mg">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <PrescribingMolecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Salicylates (systemic)" reference="{3CCDBD67-FD02-4AF8-B3EB-E54066A7BAD5}" description="Analgesic, antipyretic and anti-inflammatory agents.">
                <Molecule name="aspirin" reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" />
              </InteractionClass>
              <Severity name="Severe" ranking="5">Severe</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>
                </Abbreviated>
                <Professional>causes additive toxicity with</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>The concurrent use of salicylates (e.g. aspirin) and NSAIDs increases the risk of gastrointestinal bleeding. In addition, there is some evidence that NSAIDs may antagonise the antiplatelet effects and reduce the cardioprotective effects of low-dose aspirin. If the use of low-dose aspirin with NSAIDs cannot be avoided, the use of a proton pump inhibitor should be considered. Furthermore, concomitant use of aspirin may result in reduced levels and effects of several NSAIDs; this pharmacokinetic interaction has little clinical relevance as concurrent use of analgesic dose aspirin (or other salicylates) with NSAIDs is usually not recommended.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Avoid combination.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
      </Route>
      <Allergy>
        <Molecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin">
          <CrossSensitive>
            <PrescribingSubstanceClass reference="{5C60F191-B92F-4186-ADF5-859CB3B66E11}" name="Nonsteroidal anti-inflammatory drugs">
              <PrescribingMolecule reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" name="diclofenac sodium" />
            </PrescribingSubstanceClass>
            <AllergySubstanceClass reference="{8B9ECB52-CDC9-4460-AB40-6E3C7DF38B1E}" name="Salicylates">
              <AllergyMolecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin" />
            </AllergySubstanceClass>
          </CrossSensitive>
        </Molecule>
      </Allergy>
      <Allergy>
        <Molecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol">
          <CrossSensitive>
            <PrescribingSubstanceClass reference="{5C60F191-B92F-4186-ADF5-859CB3B66E11}" name="Nonsteroidal anti-inflammatory drugs">
              <PrescribingMolecule reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" name="diclofenac sodium" />
            </PrescribingSubstanceClass>
            <AllergySubstanceClass reference="{50227FDE-1699-4083-92FA-AA75F30A285D}" name="Paracetamol and related agents">
              <AllergyMolecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol" />
            </AllergySubstanceClass>
          </CrossSensitive>
        </Molecule>
      </Allergy>
    </Product>
    <Product reference="{EDD3FF15-CC25-46C6-80F7-2F8EF72FC502}" name="VIROSTAV TAB 30mg">
    </Product>
    <Product reference="{63B9060F-BFFF-46F0-92FD-ECB299CF917F}" name="ALPYRIN TAB 150mg">
      <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
        <Product reference="{9FE0E40F-ED39-4EA5-B274-D4FC99CD2753}" name="SPILACTONE FILM-COATED TAB 50mg">
        </Product>
        <Product reference="{96048B6A-575C-4D10-AE5B-D45DD410BAA5}" name="DICLOACT PLUS TAB" Mirror="True">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Salicylates (systemic)" reference="{3CCDBD67-FD02-4AF8-B3EB-E54066A7BAD5}" description="Analgesic, antipyretic and anti-inflammatory agents.">
                <PrescribingMolecule name="aspirin" reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <Molecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </InteractionClass>
              <Severity name="Severe" ranking="5">Severe</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>causes additive toxicity with</Abbreviated>
                <Professional>causes additive toxicity with</Professional>
                <Full>causes additional harmful effects with</Full>
                <Consumer>causes additional harmful effects with</Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>The concurrent use of salicylates (e.g. aspirin) and NSAIDs increases the risk of gastrointestinal bleeding. In addition, there is some evidence that NSAIDs may antagonise the antiplatelet effects and reduce the cardioprotective effects of low-dose aspirin. If the use of low-dose aspirin with NSAIDs cannot be avoided, the use of a proton pump inhibitor should be considered. Furthermore, concomitant use of aspirin may result in reduced levels and effects of several NSAIDs; this pharmacokinetic interaction has little clinical relevance as concurrent use of analgesic dose aspirin (or other salicylates) with NSAIDs is usually not recommended.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Avoid combination.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{CCCDB71F-E825-414C-BA3A-E0A665C10AAB}" name="DICLOFEN TAB 50mg" Mirror="True">
          <Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}">
            <ClassInteraction>
              <PrescribingInteractionClass name="Salicylates (systemic)" reference="{3CCDBD67-FD02-4AF8-B3EB-E54066A7BAD5}" description="Analgesic, antipyretic and anti-inflammatory agents.">
                <PrescribingMolecule name="aspirin" reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" />
              </PrescribingInteractionClass>
              <InteractionClass name="Nonsteroidal anti-inflammatory drugs" reference="{3848CA1B-1F1B-44D4-8F2D-CB292DD655C0}" description="NSAIDs are considered to nonspecifically inhibit both cyclooxygenase (COX)-1 and COX-2. NSAIDs are generally protein bound and may interact with other protein bound drugs.">
                <Molecule name="diclofenac sodium" reference="{B641CB56-2142-4D99-9050-711E64E87B0C}" />
              </InteractionClass>
              <Severity name="Severe" ranking="5">Severe</Severity>
              <Likelihood name="Good" ranking="3">Good</Likelihood>
              <Documentation name="Good" ranking="3">Good</Documentation>
              <Observation>
                <Abbreviated>causes additive toxicity with</Abbreviated>
                <Professional>causes additive toxicity with</Professional>
                <Full>causes additional harmful effects with</Full>
                <Consumer>causes additional harmful effects with</Consumer>
              </Observation>
              <Interaction>
                <Abbreviated>
                </Abbreviated>
                <Professional>The concurrent use of salicylates (e.g. aspirin) and NSAIDs increases the risk of gastrointestinal bleeding. In addition, there is some evidence that NSAIDs may antagonise the antiplatelet effects and reduce the cardioprotective effects of low-dose aspirin. If the use of low-dose aspirin with NSAIDs cannot be avoided, the use of a proton pump inhibitor should be considered. Furthermore, concomitant use of aspirin may result in reduced levels and effects of several NSAIDs; this pharmacokinetic interaction has little clinical relevance as concurrent use of analgesic dose aspirin (or other salicylates) with NSAIDs is usually not recommended.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Interaction>
              <Precaution>
                <Abbreviated>
                </Abbreviated>
                <Professional>Avoid combination.</Professional>
                <Full>
                </Full>
                <Consumer>
                </Consumer>
              </Precaution>
            </ClassInteraction>
          </Route>
        </Product>
        <Product reference="{EDD3FF15-CC25-46C6-80F7-2F8EF72FC502}" name="VIROSTAV TAB 30mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
        <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
        </Product>
      </Route>
      <Allergy>
        <Molecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin">
          <SubstanceClass reference="{8B9ECB52-CDC9-4460-AB40-6E3C7DF38B1E}" name="Salicylates">
            <PrescribingMolecule reference="{68EC41A6-71EE-427C-B261-03425BAA3DD3}" name="aspirin" />
          </SubstanceClass>
        </Molecule>
      </Allergy>
    </Product>
    <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
      <Allergy>
        <Molecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol">
          <SubstanceClass reference="{50227FDE-1699-4083-92FA-AA75F30A285D}" name="Paracetamol and related agents">
            <PrescribingMolecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol" />
          </SubstanceClass>
        </Molecule>
      </Allergy>
    </Product>
    <Product reference="{88817344-9B13-446B-BE00-E8B4C24C5B7A}" name="DOLO TAB 650mg">
      <Allergy>
        <Molecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol">
          <SubstanceClass reference="{50227FDE-1699-4083-92FA-AA75F30A285D}" name="Paracetamol and related agents">
            <PrescribingMolecule reference="{AC340A53-6611-425A-8A75-70E82F00B79C}" name="paracetamol" />
          </SubstanceClass>
        </Molecule>
      </Allergy>
    </Product>
    <DuplicateTherapy />
  </Interaction>
</Result>